Open AccessEffect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy
Author(s) -
Frank Bridoux,
PierreLouis Carron,
Brigitte Pegourié,
É. Alamartine,
Karine Augeul-Meunier,
Alexandre Karras,
Bertrand Joly,
MarieNoelle Péraldi,
Bertrand Arnulf,
Cécile Vigneau,
T. Lamy,
Alain Wynckel,
Brigitte Kolb,
Bruno Royer,
Nolwenn Rabot,
Lotfi Benboubker,
Christian Combe,
Arnaud Jaccard,
Bruno Moulin,
Bertrand Knebelmann,
Sylvie Chevret,
JeanPaul Fermand,
for the MYRE Study Group
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.17924
Subject(s) - medicine , hemodialysis , multiple myeloma , surgery , nephropathy , randomized controlled trial , urology , endocrinology , diabetes mellitus
Cast nephropathy is the main cause of acute kidney injury in multiple myeloma and persistent reduction in kidney function strongly affects prognosis. Strategies to rapidly remove nephrotoxic serum-free light chains combined with novel antimyeloma agents have not been evaluated prospectively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom